A detailed history of Heron Financial Group, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Heron Financial Group, LLC holds 9,786 shares of EW stock, worth $640,787. This represents 0.5% of its overall portfolio holdings.

Number of Shares
9,786
Previous 9,566 2.3%
Holding current value
$640,787
Previous $791,000 16.69%
% of portfolio
0.5%
Previous 0.44%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$81.41 - $94.33 $17,910 - $20,752
220 Added 2.3%
9,786 $923,000
Q1 2023

Apr 19, 2023

BUY
$74.26 - $84.51 $44,704 - $50,875
602 Added 6.72%
9,566 $791,000
Q4 2022

Feb 14, 2023

SELL
$68.3 - $87.44 $7,171 - $9,181
-105 Reduced 1.16%
8,964 $668,000
Q3 2022

Oct 27, 2022

BUY
$82.37 - $107.29 $3,706 - $4,828
45 Added 0.5%
9,069 $749,000
Q2 2022

Jul 29, 2022

SELL
$86.5 - $128.27 $91,690 - $135,966
-1,060 Reduced 10.51%
9,024 $858,000
Q1 2022

May 12, 2022

BUY
$101.96 - $128.34 $33,035 - $41,582
324 Added 3.32%
10,084 $1.19 Million
Q4 2021

Feb 04, 2022

SELL
$106.37 - $130.68 $2,127 - $2,613
-20 Reduced 0.2%
9,760 $1.06 Million
Q3 2021

Nov 04, 2021

SELL
$102.91 - $122.75 $2,058 - $2,455
-20 Reduced 0.2%
9,780 $1.11 Million
Q2 2021

Aug 16, 2021

BUY
$83.84 - $104.76 $30,182 - $37,713
360 Added 3.81%
9,800 $1.02 Million
Q4 2020

Feb 16, 2021

SELL
$71.69 - $91.23 $26,883 - $34,211
-375 Reduced 3.82%
9,440 $844,000
Q3 2020

Oct 15, 2020

SELL
$67.19 - $87.44 $873 - $1,136
-13 Reduced 0.13%
9,815 $787,000
Q2 2020

Jul 20, 2020

BUY
$57.54 - $76.95 $368,658 - $493,018
6,407 Added 187.28%
9,828 $667,000
Q1 2020

Apr 23, 2020

SELL
$52.41 - $81.0 $12,001 - $18,549
-229 Reduced 6.27%
3,421 $739,000
Q4 2019

Feb 14, 2020

BUY
$71.7 - $82.09 $261,705 - $299,628
3,650 New
3,650 $844,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Heron Financial Group, LLC Portfolio

Follow Heron Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heron Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Heron Financial Group, LLC with notifications on news.